iBio Inc. Shares Approach 52-Week Low - Market Mover
The shares closed 1.9% above its 52-week low of $0.53, with trading volume higher than its 30 day average
Jan 07, 2022 by Kwhen Finance Editors
iBio Inc. (IBIO) shares closed today at 1.9% above its 52 week low of $0.53, giving the company a market cap of $117M. The stock is currently down 1.6% year-to-date, down 54.2% over the past 12 months, and down 88.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%.
Trading Activity
- Trading volume this week was 5.1% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.5.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|
iBio Inc. | -4.4 | -1.6 | -54.2 | -80.9 | 2.1 |
Dow Jones Industrial Average | -0.5 | 0.2 | 21.9 | -1.4 | 24.0 |
S&P 500 Index | -0.1 | -1.4 | 27.8 | -2.5 | 28.8 |
Health Care | -1.1 | -3.5 | 19.1 | -4.6 | 22.5 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -16.7%
- The company's stock price performance over the past 12 months lags the peer average by 66.5%
Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|---|
iBio Inc. | IBIO | 0 | -1.6 | -54.2 | -80.9 | 2.1 |
Peer Avg | N/A | 7.9 | -2.0 | -32.6 | -48.6 | 26.2 |
Johnson & Johnson | JNJ | 25.4 | 0.7 | 11.5 | -3.2 | 15.8 |
Emergent Biosolutions Inc | EBS | 11.0 | 6.4 | -52.3 | -63.6 | 54.8 |
Nektar Therapeutics | NKTR | -4.8 | -5.5 | -29.0 | -54.3 | 15.5 |
Genocea Biosciences Inc | GNCA | 0 | -9.5 | -60.5 | -73.3 | 18.7 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: